KIORA PHARMACEUTICALS, INC. Proceeds from Collaborators
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Collaborators of $16.00 million for the 3-month period ending 2024-03-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromCollaborators · last filed 2026-03-25
- KIORA PHARMACEUTICALS, INC. proceeds from collaborators for the quarter ending 2024-03-31 was $16.00M.
| Period end | Proceeds from Collaborators 3 month |
|---|---|
| 2024-03-31 | $16.00M 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |